Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Challice L Bonifant

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Cytotherapy|October 13, 2018
Programmed cell death protein 1 activation preferentially inhibits CD28.CAR-T cellsSergey N Zolov, Skyler P Rietberg, Challice L Bonifant
Seminars in Hematology|December 1, 2020
Improving CAR T-cells: The next generationAndrew H Marple, Challice L Bonifant, Nirali N Shah
Cancer Immunology Research|February 21, 2019
T-cell Activity against AML Improved by Dual-Targeted T Cells Stimulated through T-cell and IL7 ReceptorsEric Krawczyk, Sergey N Zolov, Kevin Huang, et al.
Molecular and Cellular Biology|October 25, 2006
Activation of p53-dependent growth suppression in human cells by mutations in PTEN or PIK3CAJung-Sik Kim, Carolyn Lee, Challice L Bonifant, et al.
Molecular Therapy Oncolytics|September 15, 2016
Toxicity and management in CAR T-cell therapyChallice L Bonifant, Hollie J Jackson, Renier J Brentjens, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Hyper-migratory CAR T cells alleviate ovarian cancer metastatic burden and improve prognosisPraful R Nair, Eban Hanna, Saurabh Joshi, et al.
Frontiers in Immunology|May 26, 2022
Transgenic Expression of IL15 Retains CD123-Redirected T Cells in a Less Differentiated State Resulting in Improved Anti-AML Activity in Autologous AML PDX ModelsHong Mu-Mosley, Lauren Ostermann, Muharrem Muftuoglu, et al.
Frontiers in Immunology|January 10, 2022
Glycoprotein Targeted CAR-NK Cells for the Treatment of SARS-CoV-2 InfectionIlias Christodoulou, Ruyan Rahnama, Jonas W Ravich, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Detection of lymphoid and myeloid lineages in infantile B-cell acute lymphoblastic leukemia with mixed-lineage leukemia rearrangement by use of flow cytometry and cytogenetic analysisAmos Gaikwad, Challice L Bonifant, Michael Cubbage, et al.
Haematologica|July 28, 2022
Improving the anti-acute myeloid leukemia activity of CD123-specific engager T cells by MyD88 and CD40 costimulationAbishek Vaidya, Erin Doherty, Xiya Wu, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Cytotherapy|October 13, 2018
Programmed cell death protein 1 activation preferentially inhibits CD28.CAR-T cellsSergey N Zolov, Skyler P Rietberg, Challice L Bonifant
Seminars in Hematology|December 1, 2020
Improving CAR T-cells: The next generationAndrew H Marple, Challice L Bonifant, Nirali N Shah
Cancer Immunology Research|February 21, 2019
T-cell Activity against AML Improved by Dual-Targeted T Cells Stimulated through T-cell and IL7 ReceptorsEric Krawczyk, Sergey N Zolov, Kevin Huang, et al.
Molecular and Cellular Biology|October 25, 2006
Activation of p53-dependent growth suppression in human cells by mutations in PTEN or PIK3CAJung-Sik Kim, Carolyn Lee, Challice L Bonifant, et al.
Molecular Therapy Oncolytics|September 15, 2016
Toxicity and management in CAR T-cell therapyChallice L Bonifant, Hollie J Jackson, Renier J Brentjens, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Hyper-migratory CAR T cells alleviate ovarian cancer metastatic burden and improve prognosisPraful R Nair, Eban Hanna, Saurabh Joshi, et al.
Frontiers in Immunology|May 26, 2022
Transgenic Expression of IL15 Retains CD123-Redirected T Cells in a Less Differentiated State Resulting in Improved Anti-AML Activity in Autologous AML PDX ModelsHong Mu-Mosley, Lauren Ostermann, Muharrem Muftuoglu, et al.
Frontiers in Immunology|January 10, 2022
Glycoprotein Targeted CAR-NK Cells for the Treatment of SARS-CoV-2 InfectionIlias Christodoulou, Ruyan Rahnama, Jonas W Ravich, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Detection of lymphoid and myeloid lineages in infantile B-cell acute lymphoblastic leukemia with mixed-lineage leukemia rearrangement by use of flow cytometry and cytogenetic analysisAmos Gaikwad, Challice L Bonifant, Michael Cubbage, et al.
Haematologica|July 28, 2022
Improving the anti-acute myeloid leukemia activity of CD123-specific engager T cells by MyD88 and CD40 costimulationAbishek Vaidya, Erin Doherty, Xiya Wu, et al.
Pageof 5